Alvotech shares start trading on nasdaq iceland main market

Reykjavik, iceland, dec. 08, 2022 (globe newswire) -- alvotech (nasdaq: alvo), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced that trading in its shares will move from the nasdaq iceland first north growth market (“first north”) to the nasdaq iceland main market (“main market”), starting today december 8, 2022. the “alvo” stock market symbol for alvotech remains unchanged and trade on the nasdaq u.s. stock exchange is not affected.  a main market listing in iceland can increase a company's visibility and, subject to meeting certain conditions, may result in inclusion in icelandic and international indexes.
ALVO Ratings Summary
ALVO Quant Ranking